BACKGROUND: The 6 min walk test (6-MWT) is a simple and popular test for evaluating functional status in patients with chronic heart failure (CHF). However, the prognostic value of the 6-MWT in a large, representative sample of CHF patients, and in patients with different degrees of left ventricular systolic dysfunction (LVSD) remains unclear. METHODS AND RESULTS: Of an initial population of 1592 patients, 212 died representing a crude death rate of 13.3%. In surviving patients, the median time to follow-up period was 36.6 months [inter-quartile range (IQR) 28-45 months]. Five variables remained independent predictors of all-cause mortality; decreasing 6-MWT distance, self-perceived signs of breathlessness at night (SOBAN), beta-blocker usage, elevated log NT-proBNP, and reduced haemoglobin concentration. We also dichotomized our analysis by LVSD status (<or=mild LVSD or >mild LVSD). For patients with >mild LVSD, 6-MWT remained an important prognostic indicator but not in patients with <or=mild LVSD. CONCLUSION: The 6-MWT is an important independent predictor of mortality in CHF patients, and this was especially evident in patients with >mild LVSD. The 6-MWT provides little prognostic utility in patients with <or=mild LVSD. While log NT-proBNP was the most potent independent predictor, an additive prognostic effect was evident with the additional selection of 6-MWT. Patients' self-perceived symptoms, especially SOBAN was an independent predictor of mortality in our patients.
BACKGROUND: The 6 min walk test (6-MWT) is a simple and popular test for evaluating functional status in patients with chronic heart failure (CHF). However, the prognostic value of the 6-MWT in a large, representative sample of CHFpatients, and in patients with different degrees of left ventricular systolic dysfunction (LVSD) remains unclear. METHODS AND RESULTS: Of an initial population of 1592 patients, 212 died representing a crude death rate of 13.3%. In surviving patients, the median time to follow-up period was 36.6 months [inter-quartile range (IQR) 28-45 months]. Five variables remained independent predictors of all-cause mortality; decreasing 6-MWT distance, self-perceived signs of breathlessness at night (SOBAN), beta-blocker usage, elevated log NT-proBNP, and reduced haemoglobin concentration. We also dichotomized our analysis by LVSD status (<or=mild LVSD or >mild LVSD). For patients with >mild LVSD, 6-MWT remained an important prognostic indicator but not in patients with <or=mild LVSD. CONCLUSION: The 6-MWT is an important independent predictor of mortality in CHFpatients, and this was especially evident in patients with >mild LVSD. The 6-MWT provides little prognostic utility in patients with <or=mild LVSD. While log NT-proBNP was the most potent independent predictor, an additive prognostic effect was evident with the additional selection of 6-MWT. Patients' self-perceived symptoms, especially SOBAN was an independent predictor of mortality in our patients.
Authors: Jakob Ledwoch; Jennifer Franke; Edith Lubos; Peter Boekstegers; Miriam Puls; Taoufik Ouarrak; Stephan von Bardeleben; Christian Butter; Joachim Schofer; Ralf Zahn; Hüsseyin Ince; Jochen Senges; Horst Sievert Journal: Clin Res Cardiol Date: 2017-12-05 Impact factor: 5.460
Authors: Alexander X Lo; John P Donnelly; Gerald McGwin; Vera Bittner; Ali Ahmed; Cynthia J Brown Journal: Am J Cardiol Date: 2015-01-06 Impact factor: 2.778
Authors: Daniel E Forman; Jerome L Fleg; Dalane W Kitzman; Clinton A Brawner; Ann M Swank; Robert S McKelvie; Robert M Clare; Stephen J Ellis; Mark E Dunlap; Vera Bittner Journal: J Am Coll Cardiol Date: 2012-11-21 Impact factor: 24.094
Authors: Debra E Irwin; Charles A Atwood; Ron D Hays; Karen Spritzer; Honghu Liu; James F Donohue; Nancy Kline Leidy; Susan E Yount; Darren A DeWalt Journal: Qual Life Res Date: 2014-10-12 Impact factor: 4.147
Authors: Ralph A H Stewart; Dominika Szalewska; Lilin She; Kerry L Lee; Mark H Drazner; Barbara Lubiszewska; Dragana Kosevic; Permyos Ruengsakulrach; José C Nicolau; Benoit Coutu; Shiv K Choudhary; Daniel B Mark; John G F Cleland; Ileana L Piña; Eric J Velazquez; Andrzej Rynkiewicz; Harvey White Journal: JACC Heart Fail Date: 2014-07-09 Impact factor: 12.035